Abdominal Pain Clinical Trial
Official title:
Transvaginal Pelvic Ultrasound in the ED
NCT number | NCT02547857 |
Other study ID # | HSR 14-3918 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | June 15, 2015 |
Last updated | December 23, 2016 |
Start date | September 2015 |
Pelvic ultrasound is frequently performed in the ED in non-pregnant women to assess for ovarian pathology, though its use has not been described in the medical literature. This observational study aims to describe its use in clinical ED practice.
Status | Completed |
Enrollment | 114 |
Est. completion date | |
Est. primary completion date | October 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age >= 18 years old female - ED bedside transvaginal ultrasound to be performed in a non-pregnant woman with at least one ovary - Willing to discuss how they are doing at 7-10 days via phone - Valid phone number Exclusion Criteria: - If a diagnosis of ovarian torsion, mass, TOA or other ovarian pathology is known before ED ultrasound - Previously enrolled in this study |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Hennepin County Medical Center | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Minneapolis Medical Research Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Method of finding ovaries | Will choose from: Adjacent to pelvic vessels Followed out from uterine cornu No particular method used |
8 hours (or less, this will measure what occurs during an ED stay) | No |
Other | Experience of sonographer | Choose from: G1 G2 G3-G5 Physician Assistant (PA) Attending US tech |
8 hours (or less, this will measure what occurs during an ED stay) | No |
Other | Pelvic physical exam characteristics | Was there tenderness on the exam (right/left adnexa, suprapubic region, no tenderness)? Were any masses felt? (right/left adnexa, suprapubic, no mass) | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Primary | Change in diagnosis before/after pelvic US | The treating physician will be queried the likelihood of EMERGENT and NON-EMERGENT ovarian pathology before and after pelvic US using the following scale: Definite, Probable, Possible, Very Unlikely. The ED tests reviewed before each of these judgements will be noted. EMERGENT is defined as ovarian torsion or tubo-ovarian abscess (TOA). NON-EMERGENT is defined as all other causes, including ovarian cyst, ovarian mass, ovarian malignancy, adnexal mass). The clinician will also free text the most likely diagnosis. A change of two or more levels (eg definite to possible, definite to very unlikely, probable to very unlikely, or vice versa) will be assumed to be a significant change in diagnosis. | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Primary | Change in management plan before/after pelvic US | The treating physician will choose from the following regarding the management plan before/after the pelvic US: outpatient referral to OB/GYN, formal pelvic US after bedside US, consult GYN in the ED, urgent/emergent operative intervention, None of the above. Any difference in management before/after pelvic US will be considered a significant change in management. | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Sonographic visualization of ovaries | yes/no | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Duration of pelvic US | Less than 5 minutes, 5-10 minutes, more than 10 minutes | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Ovary enlargement | Were the ovaries larger than 3.5 x 2 cm in any plane? yes/no answer | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Ovarian tenderness, sonographic | As a dichotomous yes/no. This will be correlated to final diagnosis. How many women with a non-tender ovary ended up with EMERGENT pathology? How many had NON-EMERGENT pathology? | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Ovarian blood flow | The physician will determine if the ovarian flow is normal in a dichotomous yes/no answer. (if performed) | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | ED disposition after visit | This will measure if the patient is discharged from the ED or admitted to the hospital | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Final ED diagnosis | Two questions will be answered: Ovarian Pathology, Emergency (tubo-ovarian abscess, torsion) Ovarian Pathology, Non-Emergency (cyst, mass, malignancy) Non-ovarian problem Question 2: Final ED diagnosis after all work-up: (select all that apply) checkbox ed_final_dx_2___1 ovarian cyst ed_final_dx_2___2 ovarian mass ed_final_dx_2___3 ovarian torsion ed_final_dx_2___4 tubo-ovarian abscess ed_final_dx_2___5 other ovarian pathology ed_final_dx_2___6 adnexal mass (non-ovarian) ed_final_dx_2___7 Pelvic Inflammatory Disease ed_final_dx_2___8 Abdominal pathology (appendicitis, diverticulitis, SBO, others) ed_final_dx_2___9 Non-specific abdominal pain ed_final_dx_2___10 None of the above and no ovarian pathology suspected |
8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | 7-day follow-up | Whether another facility was visited, whether a procedure occurred, and what else happened during this stay. Patients will be attempted to be contacted three times. | 7 days | No |
Secondary | Correlation between ED US and Formal US | If a formal US is obtained, the reading will be abstracted and compared to the ED US for the following: ovary visualization, ovary size, ovarian flow, final diagnosis, and any other abnormality in free text. | 8 hours (or less, this will measure what occurs during an ED stay) | Yes |
Secondary | Final impression for ED ultrasound with regards to ovaries | NORMAL or ABNORMAL. If abnormal, the abnormality will be described. | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Secondary | Formal pelvic US | Was this study obtained? dichotomous yes/no. And why was a formal pelvic US obtained? (abnormality of ovaries on bedside US; other abnormality on bedside US; unable to visualize ovaries on bedside US; good visualization of all structures and all structures normal, but post-test probability still high; Other (free text). )The exact reason will then be listed in free text. | 8 hours (or less, this will measure what occurs during an ED stay) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04682860 -
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide
|
Phase 4 | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 | |
Completed |
NCT02923245 -
POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound
|
N/A | |
Completed |
NCT02676232 -
DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Recruiting |
NCT00209807 -
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
|
Phase 4 | |
Terminated |
NCT01410071 -
Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction
|
N/A | |
Terminated |
NCT01736280 -
Evaluating and Treating Potential Research Participants With Digestive Disorders
|
N/A | |
Enrolling by invitation |
NCT04104867 -
Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy
|
N/A | |
Completed |
NCT03574727 -
Abdominal Cutaneous Nerve Entrapment Syndrome
|
||
Completed |
NCT04614649 -
Right Iliac Fossa Treatment-Turkey Audit
|
||
Completed |
NCT05438654 -
Improvement of Diagnostic Approach Using PoCUS for Right Upper Quadrant Abdominal Pain
|
N/A | |
Completed |
NCT06423586 -
Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS
|
N/A | |
Completed |
NCT03558009 -
Epidemiological Analysis for Hereditary Angioedema Disease
|
||
Terminated |
NCT03148288 -
Vitamin D Supplementation in IBS
|
N/A | |
Completed |
NCT03708874 -
Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis
|
||
Withdrawn |
NCT04408872 -
EUS vs EGD in Emergency Room Patients Referred for EGD
|
N/A | |
Recruiting |
NCT02594774 -
Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents
|
N/A | |
Recruiting |
NCT02105090 -
Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
|
Phase 4 |